This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Modlin JF, Coffey DJ. Poliomyelitis, poliovaccine and the post-poliomyelitis syndrome. In: Scheld WM, Whitley RJ, Durack DT, eds. Infections of The Central Nervous System. Lippincott-Raven. 1997; 57–72
World Health Organization. Fact Sheet No 114. April 2003. (http://www.who.int/mediacentre/factsheets/fs114/en/).
Centers for Disease control and Prevention (CDC). Paralytic poliomyelitis—United States, 1980–1994. MMWR 1997; 46:79–83.
Centers for Disease control and Prevention (CDC). Imported vaccine-associated paralytic poliomyelitis—United States, 2005. MMWR 2005; 55:97–99.
Centers for Disease control and Prevention (CDC). International Notes. Certification of Poliomyelitis Eradication—The Americas, 1994. MMWR 1994; 43:720–722.
Centers for Disease control and Prevention (CDC). Progress toward interruption of wild poliovirus transmission—worldwide, January 2005-March 2006. MMWR 2006; 55:458–462.
7. Ren R, Racaniello VR. Poliovirus spreads from muscle to the central nervous system by neural pathways. J Infect Dis. 1992; 166:747–752.
8. Rekand T, Karlsen B, Langeland N, Aarli JA. Long-term follow-up of patients with nonparalytic poliomyelitis. Arch Phys Med Rehabil. 2002; 83:533–537.
9. Johnson RT. Late progression of poliomyelitis paralysis: discussion of pathogenesis. Rev Infect Dis. 1984; 6:S568–570.
10. Trojan DA, Cashman NR, Shapiro S, Tansey CM, Esdaile JM. Predictive factors for post-poliomyelitis syndrome. Arch Phys Med Rehabil. 1994; 75:770–777.
11. Dalakas MC, Elder G, Hallett M, et al. A long-term follow-up study of patients with post-poliomyelitis neuromuscular symptoms. N Engl J Med. 1986; 314:959–963.
12. Finkelstein SD. Polioviruses. In: Connor DH, Chandler FW, Schwartz DA, Manz HJ, Lack EE, eds. Pathology of Infectious Diseases. Stamford, CT: Appleton & Lange. 1997; 259–263.
13. Petitjean J, Quibriac M, Freymuth F, Fuchs F. Specific detection of enteroviruses in clinical samples of molecular hybridization using poliovirus subgenomic riboprobes. J Clin Microbiol. 1990; 28:307–311.
14. Yang CF, De L, Holloway BP, Pallansch MA, Kew OM. Detection and identification of vaccine-related polioviruses by the polymerase chain reaction. Virus Res. 1991; 20:157–159.
15. Nagata N, Iwasaki T, Ami Y, et al. Differential localization of neurons susceptible to enterovirus 71 and poliovirus type 1 in the central nervous system of cynomolgus monkeys and intravenous inoculation. J Gen Virol. 2004; 85:2981–2989.
16. Atkinson WL, Pickering LK, Schwartz B, et al. General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP). MMWR 2002; 51:1–35.
Centers for Disease control and Prevention (CDC). Recommendations of the Advisory Committee on Immunization Practices: revised recommendations for routine poliomyelitis vaccination. MMWR 1999; 48:590.
Centers for Disease control and Prevention (CDC). Progress towards global eradication of poliomyelitis, 2001. MMWR 2002; 51:253–256.
19. Rotbart HA. Viral meningitis and the aseptic meningitis syndrome. In: Scheld WM, Whitley RJ, Durack DT, eds. Infections of the Central Nervous System. Philadelphia, PA:Lippincott-Raven. 1997; 23–33.
Modlin JF. Coxsackieviruses, echoviruses, and newer enteroviruses. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, & Bennett's Principles and Practices of Infectious Diseases. Churchill Livingston. 2005; 2149–2161.
21. Rotbart HA. Enteroviral infections of the central nervous system. Clin Infect Dis. 1995; 20:971–981.
22. Rotbart HA, Viral meningitis. Semin Neurol. 2000; 20:277–292.
23. Modlin JF, Degan R, Berlin LE, et al. Focal encephalitis with enterovirus infections. Pediatrics 1991; 88:841–845.
Modlin JF. Enteroviruses: coxsackieviruses, echoviruses, and newer enteroviruses. In: Long SS, Pickering LK, Prober CG. eds. Principles and Practices of Pediatric Infectious Diseases. Churchill Livingston. 2003; 1179–1188.
Cherry JD. Enteroviruses and Parechoviruses. In: Feigin RD, Cherry JD, Demmeler GJ, Kaplan SL, eds. Textbook of Pediatric Infectious Diseases. Saunders. 2004; 1984–2041.
26. Huang C, Liu C, Chang Y, Chen C, Wang S, Yeh T, Neurologic complications in children with enterovirus 71 infection. N Engl J Med. 1999; 341:936–942.
27. Romero JR, Newland JG. Viral meningitis and encephalitis: Traditional and emerging viral agents. Semin Pediatr Infect Dis. 2003; 14:72–82.
28. Graber D. Acute transverse myelitis and Coxsackie A9 virus infection. Pediatr Infect Dis J. 1994; 13:77.
29. Kandolf R, Hofschneider PH. Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus: full length, reverse transcribed recombinant cDNA generates infectious virus in mammalian cells. Proc Natl Acad Sci USA. 1985; 82:4818–4822.
30. Cova L, Kopecka H, Aymard M, Girard M. Use of cRNA probes for the detection of enteroviruses by molecular hybridization. J Med Virol. 1988; 24:11–18.
31. Abzug MJ, Cloud G, Bradley J. Double blind placebo-controlled trial of Pleconaril in infants with enterovirus meningitis. Pediatr Infect Dis J. 2003; 22:335–340.
Red Book. Report of the Committee on Infectious Diseases. Enterovirus (Nonpoliovirus) Infections. American Academy of Pediatrics. Elk Groove, IL. 2006; 284–285.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science + Business Media, LLC
About this chapter
Cite this chapter
Abuelreish, M.A., Rathore, M.H. (2008). Picornaviruses. In: The Neurological Manifestations of Pediatric Infectious Diseases and Immunodeficiency Syndromes. Infectious Disease™. Humana Press. https://doi.org/10.1007/978-1-59745-391-2_3
Download citation
DOI: https://doi.org/10.1007/978-1-59745-391-2_3
Publisher Name: Humana Press
Print ISBN: 978-1-58829-967-3
Online ISBN: 978-1-59745-391-2
eBook Packages: MedicineMedicine (R0)